Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 190Leukemia, Lymphocytic, Chronic, B-Cell 69Myelodysplastic Syndromes 48Recurrence 30Leukemia 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Lymphoma, Mantle-Cell 21Leukemia, Myelomonocytic, Chronic 20Leukemia, Biphenotypic, Acute 15Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 14Hematologic Neoplasms 14Lymphoma, Non-Hodgkin 13Lymphoma 13Burkitt Lymphoma 13Lymphoma, B-Cell, Marginal Zone 12Multiple Myeloma 11Lymphoma, Large B-Cell, Diffuse 11Neoplasms 10Waldenstrom Macroglobulinemia 8Myeloproliferative Disorders 8Lymphoma, Follicular 8Lymphoma, B-Cell 7Neoplasm, Residual 6Leukemia, Myeloid 5Blastic Plasmacytoid Dendritic Cell Neoplasm 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4GATA2 Deficiency 4Leukemia, Monocytic, Acute 3Leukemia, B-Cell 3

Interventions

Arsenic Trioxide 6Tretinoin 5venetoclax 1arsenous acid 1Mitoxantrone 1Methotrexate 1Mercaptopurine 1Magnetic Resonance Spectroscopy 1Lisaftoclax 1Idarubicin 1Gemtuzumab 1Gadolinium 1Fluorodeoxyglucose F18 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Promyelocytic, Acute × venetoclax × 1 year × Clear all
NCT07187505 2025-09-23

Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic Leukemia

Anhui Medical University

Phase NA Active not recruiting
28 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡